No Detail Found!

VKORC1 gene polymorphism (-1639G>A) in warfarin therapy patients of Pakistani population

Author(s)
Muhammad Bilal Ghafoor Department of Haematology, University of Health Sciences, Lahore,Pakistan
Faiza Yasmeen Department of Haematology, University of Health Sciences, Lahore,Pakistan
Abdul Wadood Khalid Department of Pathology, Punjab Institute of Cardiology (PIC),Lahore, Pakistan
Ghulam Mustafa Department of Human Genetics and Molecular Biology, University of Health Sciences,Lahore,Pakistan
Shagufta Khaliq Department of Human Genetics and Molecular Biology, University of Health Sciences,Lahore,Pakistan
Shahida Mohsin Department of Haematology, University of Health Sciences, Lahore,Pakistan
Abstract
Objective: To observe vitamin K epoxide reductase complex subunit 1-1639 G>A polymorphism in patients resistant to warfarin therapy, and to calculate the allele frequency of the polymorphism in local patients. Method: The cross-sectional case-control study was conducted at the Punjab Institute of Cardiology, Lahore, from 2013 to 2014 and comprised patients with heart valve replacement. Thy were divided into warfarin-resistant group 1 taking 10mg/day, 70mg/week and control group 2 taking a standard dose of 5mg/day, 35mg/week. The vitamin K epoxide reductase complex subunit 1-1639 G>A polymorphism analysis was done by polymerase chain reaction, followed by restriction fragment length polymorphism technique. Data was analysed using SPSS 20. Results: Of the 146 patients, there were 73(50%) in each of the two groups. In group 1, there were 37(50.68%) males and 36(49.32%) were females with an overall mean age of 33±12 years, while group 2 had 36(49.32%) males and 37(50.68%) females with an overall mean age of 37±13 years. There were no signifi cant differences in mean values of age, serum cholesterol, triglycerides and albumin levels between the groups (p>0.05). The G allele was the most frequently found in both groups, with 140(96%) in group-1 and 137(94%) in group-2. Overall, the homozygous GG genotype was signifi cantly higher in the sample 132(90.4%) (pA polymorphism alone may not be the dominant genetic factor associated with warfarin response variability.
Publication Details
Page(s) 418-423
Published Journal: Journal of Pakistan Medical Association, Volume: 72, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
single nucleotide polymorphism, Warfarin, 2022), VKORC1 gene, PCR-RFLP. (JPMA 72: 418
0

Citations

0

Downloads

96

Views